Literature DB >> 25016193

Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments.

Ludwig Hoellein1, Ulrike Holzgrabe2.   

Abstract

Regular quality control and post-marketing surveillance of pharmaceuticals has been a critical challenge for countries of the developing world ever since. Counterfeit and substandard medicines are widely distributed and the real extent of their prevalence still remains unknown. Compendial protocols and methods utilizing high-performance liquid chromatography (HPLC) which are described in the major pharmacopoeias are widely applied for the quality control of a compound. They often require expensive solvents, delicate reagents and/or sophisticated apparatus, and may not be applicable and affordable for laboratories with limited capabilities. Simple but robust HPLC methods for the determination of five commonly used antimalarial agents, i.e. amodiaquine, mefloquine, proguanil, artemether and lumefantrine, were developed and their suitability for routine use in resource-restraint environments is discussed. They solely require readily available chemicals and solvents and exhibit a high grade of ruggedness.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimalarials; Counterfeit and substandard medicines; Essential medicines; Modular HPLC; Quality control

Mesh:

Substances:

Year:  2014        PMID: 25016193     DOI: 10.1016/j.jpba.2014.06.013

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  9 in total

1.  Survey to Identify Substandard and Falsified Tablets in Several Asian Countries with Pharmacopeial Quality Control Tests and Principal Component Analysis of Handheld Raman Spectroscopy.

Authors:  Tomoko Kakio; Hitomi Nagase; Takashi Takaoka; Naoko Yoshida; Junichi Hirakawa; Susan Macha; Takashi Hiroshima; Yukihiro Ikeda; Hirohito Tsuboi; Kazuko Kimura
Journal:  Am J Trop Med Hyg       Date:  2018-03-29       Impact factor: 2.345

2.  Development of single- and multiplex immunoassays for rapid detection and quantitation of amodiaquine in ACT drugs and rat serum.

Authors:  Jingqi Qian; Mian Wang; Zhaoxiang Wang; Rui Feng; Jiaqi Zhang; Chencheng Ye; Man Zhang; Baomin Wang; Liwang Cui
Journal:  Anal Bioanal Chem       Date:  2021-11-30       Impact factor: 4.478

3.  Development and application of immunoassays for rapid quality control of the antimalarial drug combination artesunate-mefloquine.

Authors:  Jingqi Qian; Mian Wang; Man Zhang; Rui Feng; Jiaqi Zhang; Chencheng Ye; Baomin Wang; Liwang Cui
Journal:  J Pharm Biomed Anal       Date:  2021-08-26       Impact factor: 3.571

4.  Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study.

Authors:  Benjamin J Visser; Janneke Meerveld-Gerrits; Daniëlle Kroon; Judith Mougoula; Rieke Vingerling; Emmanuel Bache; Jimmy Boersma; Michèle van Vugt; Selidji T Agnandji; Harparkash Kaur; Martin P Grobusch
Journal:  Malar J       Date:  2015-07-15       Impact factor: 2.979

Review 5.  Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.

Authors:  Huma Rasheed; Ludwig Höllein; Ulrike Holzgrabe
Journal:  Front Pharmacol       Date:  2018-08-31       Impact factor: 5.810

6.  Green Analytical Methods of Antimalarial Artemether-Lumefantrine Analysis for Falsification Detection Using a Low-Cost Handled NIR Spectrometer with DD-SIMCA and Drug Quantification by HPLC.

Authors:  Moussa Yabré; Ludivine Ferey; Abdoul Karim Sakira; Camille Bonmatin; Clotilde Fauré; Touridomon Issa Somé; Karen Gaudin
Journal:  Molecules       Date:  2020-07-27       Impact factor: 4.411

7.  Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.

Authors:  Graham Lawson; John Ogwu; Sangeeta Tanna
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

Review 8.  Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons.

Authors:  Ludwig Hoellein; Eliangiringa Kaale; Yonah Hebron Mwalwisi; Marco H Schulze; Carina Vetye-Maler; Ulrike Holzgrabe
Journal:  Risk Manag Healthc Policy       Date:  2022-04-29

Review 9.  Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.

Authors:  Huma Rasheed; Ludwig Hoellein; Khalid Saeed Bukhari; Ulrike Holzgrabe
Journal:  J Pharm Policy Pract       Date:  2019-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.